▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #721 by analyst upside · 2026-09-09
MGTX
MeiraGTx Holdings plc
Healthcare · Market Cap $1B · P/E 15.6x
ANALYST PRICE TARGET
+117.5%
implied upside to consensus target
Current Price $13.53
Consensus Target $29.43
Bull Target $50.0
Bear Target $19.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
5
Hold
0
Sell
0
52-Week Low $6.62
52-Week High $15.35
YTD Return +73.2%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) 15.6x
Forward P/E N/A
EPS (TTM) $0.87
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $398M
Profit Margin 19.9%
52-WEEK RANGE
52-Week Low $6.62
52-Week High $15.35
Current Price $13.53
Bear Target $19.0
Bull Target $50.0
● Now $13.53 ● Target $29.43
TRADING DATA
Avg Volume 854K
YTD Return +73.2%
Analyst Count 7
Consensus Buy
Upside to Target +117.5%
Last Updated 2026-09-09

ANALYST SUMMARY

MeiraGTx Holdings plc (MGTX) is currently trading at $13.53 with a Wall Street consensus price target of $29.43, implying potential upside of 117.5% over the next 12 months. 7 analysts currently cover MGTX, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $50.0, while the most cautious has a target of $19.0.

MGTX operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 73.2% year-to-date and is currently trading near the upper end of its 52-week range of $6.62 – $15.35.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GTBIF +105.7%
Green Thumb Industries Inc.
$2B · P/E 14.4x · Buy
APMD +74.8%
Apnimed, Inc.
$1B · P/E 11.8x · Buy
OMER +72.6%
Omeros Corporation
$1B · P/E 11.6x · Hold
INVA +64.0%
Innoviva, Inc.
$2B · P/E 5.0x · Buy
ZVRA +97.2%
Zevra Therapeutics, Inc.
$753M · P/E 13.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MGTX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

RBC Capital - Reiterated
Outperform → Outperform 2026-08-14 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-08 Building track record
HC Wainwright & Co. reit
Buy → Buy 2026-07-08 31% win rate (48 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-05-15 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-04-22 14% win rate (7 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-04-17 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-04-01 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-03-27 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
16/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →